1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9436)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22058)
  2. Department of Medicine (22036)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5511)
  2. Elsevier Inc. (2650)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22058)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of ICU admission of patients with progressive metastatic gastrointestinal (GI) cancer
    Meeting Abstract

    Epstein, A. S.; Yang, A.; Colbert, L.; Voigt, L.; Meadows, J.; Goldberg, J.; Saltz, L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy of cabozantinib (C) vs everolimus (E) in patients (pts) with advanced renal cell carcinoma (RCC) and bone metastases (mets) from the phase III METEOR study
    Meeting Abstract

    Escudier, B. J.; Powles, T.; Motzer, R. J.; Olencki, T.; Aren, O. R.; Oudard, S.; Bracarda, S.; Tomczak, P.; Castellano, D. E.; Appleman, L. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Treatment beyond progression with nivolumab (nivo) in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study
    Meeting Abstract

    Escudier, B.; Motzer, R. J.; Sharma, P.; Wagstaff, J.; Plimack, E. R.; Hammers, H. J.; Donskov, F.; Gurney, H.; Sosman, J. A.; Zalewski, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II basket study of the oral TRK inhibitor LOXO-101 in adult subjects with NTRK fusion-positive tumors
    Meeting Abstract

    Drilon, A. E.; Hong, D. S.; Cruickshank, S.; Deegan, M.; Ku, N.; Hyman, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Drilon, A. E.; Camidge, D. R.; Ou, S. H. I.; Clark, J. W.; Socinski, M. A.; Weiss, J.; Riely, G. J.; Winter, M.; Wang, S. C.; Monti, K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS)
    Meeting Abstract

    Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Elias, A. D.; Pierson, R. F.; Knoblauch, R. E.; Park, Y. C.; Wang, G. C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS) in combination with paclitaxel (Pac) in patients (pts) with triple negative breast cancer (TNBC)
    Meeting Abstract

    DeMichele, A.; Harding, J. J.; Telli, M. L.; Munster, P. N.; McKay, R.; Iliopoulos, O.; Orford, K. W.; Bennett, M. K.; Mier, J. W.; Owonikoko, T. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation between comprehensive molecular profiling and clinical outcomes in patients with colorectal liver metastases
    Meeting Abstract

    Connell, L. C.; Sanchez-Vega, F.; Boucher, T. M.; Yaeger, R. D.; Schultz, N.; Cercek, A.; Hechtman, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 1/2 study combining ipilimumab with abiraterone acetate plus prednisone in chemotherapy- and immunotherapy-naive patients with progressive metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Kuzel, T.; Cetnar, J. P.; Rathkopf, D. E.; Morris, M. J.; Alumkal, J. J.; Butler, A.; Curley, T.; Hullings, M.; Buddle, J. R.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save